Optimising Peptide Receptor Radionuclide Therapy (PRRT) - (submitted abstracts) — ASN Events

Optimising Peptide Receptor Radionuclide Therapy (PRRT) - (submitted abstracts) — ASN Events

Optimising Peptide Receptor Radionuclide Therapy (PRRT) - (submitted abstracts)

Chairs: Richard Wahl & Andrei Iagaru

PET/CT based dosimetry for ⁹⁰Y-DOTATOC treatment of neuroendocrine cancer (#13)

John Sunderland

Personalized ¹⁷⁷Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumors: a simulation study (#14)

Jean-Mathieu Beauregard

⁶⁸Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors – a head-to-head comparison with DOTATOC and FDG PET/CT (#15)

Michael Lassmann

Evaluation of Somatostatin, CXCR4 Chemokine and Endothelin A Receptor Expression in a Large Series of Paragangliomas (#16)